AstraZeneca has begun the global withdrawal of its Covid-19 vaccine Vaxzevria, citing a surplus of updated vaccines.
Farmacêutica justificou a decisão com a falta de procura pelo fármaco e o excesso de vacinas disponíveis no mercado.
AstraZeneca withdraws Covid-19 vaccine globally due to surplus of updated vaccines. Admitted vaccine can cause blood clot ...
The firm said the decision was taken because of a decline in demand for the vaccine.
"As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the ...
Drugmaker AstraZeneca is reportedly pulling its COVID-19 vaccine from global markets due to a surplus of updated alternatives ...
One of those seeking compensation is for injuries linked to AstraZeneca's vaccine is father-of-two and IT engineer Jamie ...
AstraZeneca has begun the worldwide withdrawal of its COVID vaccine - ending an era in which it saved millions of lives while being dogged by controversy. The jab, developed at Oxford University, was ...
The company faced a class-action lawsuit that claimed the vaccine caused TTS – which stands for Thrombosis with ...
AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision. It said the rise of new coronavirus variants meant demand had shifted to the newer updated vaccines.
A vacina contra a covid-19 da Astrazeneca foi oficialmente retirada do mercado europeu. Segue-se todo o mercado mundial numa iniciativa da própria farmacêutica.
, opens new tab said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic. The company also said it ...